EyePoint, Inc.
EYPT • NASDAQ
EyePoint, Inc. is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Jay S. Duker, with a market cap of $1.0B.
CEOJay S. Duker
Next Earnings
Upcoming earnings announcement for EyePoint, Inc.
Date
Wednesday, May 6, 2026 (in a month)
Timing
Before Market Open (7:00 AM New York)
Fiscal Period
Q1 2026
EPS Estimate
-$0.80
Revenue Estimate
$331.7K
Earnings History
Past 12 earnings reports for EyePoint, Inc.
| Date | Period | EPS | EPS Surprise | Revenue | Rev. Surprise | Filing |
|---|---|---|---|---|---|---|
| Mar 4, 2026 | Q4 2025 | -$0.81Est: -$0.76 | -6.6% | $620.0KEst: $819.5K | -24.3% |  10-K |
| Nov 5, 2025 | Q3 2025 | -$0.85Est: -$0.77 | -10.4% | $966.0KEst: $4.6M | -78.9% | 10-Q |
| Aug 6, 2025 | Q2 2025 | -$0.85Est: -$0.75 | -13.3% | $5.3MEst: $6.8M | -22.1% | 10-Q |
| May 7, 2025 | Q1 2025 | -$0.65Est: -$0.55 | -18.2% | $24.5MEst: $8.1M | +202.3% | 10-Q |
| Mar 5, 2025 | Q4 2024 | -$0.64Est: -$0.48 | -33.3% | $11.6MEst: $11.0M | +5.2% | 10-K |
| Nov 7, 2024 | Q3 2024 | -$0.54Est: -$0.55 | +1.8% | $10.5MEst: $9.9M | +6.0% | 10-Q |
| Aug 7, 2024 | Q2 2024 | -$0.58Est: -$0.52 | -11.5% | $9.5MEst: $9.6M | -1.2% | 10-Q |
| May 8, 2024 | Q1 2024 | -$0.55Est: -$0.42 | -31.0% | $11.7MEst: $9.9M | +17.8% | 10-Q |
| Mar 7, 2024 | Q4 2023 | -$0.33Est: -$0.49 | +32.7% | $14.0MEst: $8.9M | +57.6% | 10-K |
| Nov 1, 2023 | Q3 2023 | -$0.33Est: -$0.51 | +35.3% | $15.2MEst: $7.5M | +102.2% | — |
| Aug 2, 2023 | Q2 2023 | -$0.57Est: $0.41 | -239.0% | $9.1MEst: $79.0M | -88.5% | 10-Q |
| May 3, 2023 | Q1 2023 | -$0.56Est: -$0.68 | +17.6% | $7.7MEst: $7.4M | +3.4% | — |